Navigation Links
Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile
Date:8/5/2014

tatements. Important factors that could cause actual results to differ materially from those reflected in Synthetic Biologics' forward-looking statements include, among others, our inability to timely commence or complete the clinical trials consistent with our current expectations and otherwise demonstrate the ability of SYN-004 to have a significant impact on mitigating the effects of C. difficile, our ability to successfully manufacture cGMP product, receive regulatory approvals for or to commercialize a new product candidate to prevent C. diff infection and other factors described in Synthetic Biologics' report on Form 10-K for the year ended December 31, 2013 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

1This information is an estimate derived from the use of information under license from the following IMS Health Incorporated information service: CDM Hospital database for full year 2012. IMS expressly reserves all rights, including rights of copying, distribution and republication.

Logo - http://photos.prnewswire.com/prnh/20130522/MM19465LOGO


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. "Sitting Ducks" No Longer: Advance Flu Warning Permits Creation of Replikins Custom Synthetic Flu Vaccine in Animals
2. Synthetic Biology: Emerging Global Markets
3. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
4. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
5. Startling results in synthetic chemistry presented in Nature Chemistry
6. Adeona Becomes Synthetic Biologics, Inc.
7. Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
8. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
9. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
10. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
11. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... San Jose, California (PRWEB) May 06, 2015 ... – Quantum Dots, a type of nanomaterial with ... the fastest-growing product in the global nanophotonics materials ... properties of quantum dots due to quantum confinement ... use in a wide range of scientific, technological, ...
(Date:5/6/2015)... Park Systems , world-leader in ... high vacuum AFM system in the market that meets ... manufacturing. Park NX-Hivac is ideal for academic and industrial ... highly doped semiconductor processing where more highly sophisticated failure ... vacuum scanning spreading resistance microscopy (SSRM) of Park NX-Hivac ...
(Date:5/5/2015)... 2015 RURO, Inc., a leading LIMS, ... 7, the latest major content upgrade to its bestselling, ... Upgrade is a significant advancement of FreezerPro® system ... users experience, while also simplifying , ... , Download available immediately for free to ...
(Date:5/5/2015)... 2015 VetStem Biopharma, proudly announces ... Jeffrey Schaffer, DVM, as Director of Veterinary Professional ... of experience in the veterinary regenerative medicine field ... our veterinarian lead organization”. Dr. Alexis Nahama, ... will be responsible for all technical activities in ...
Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3RURO Releases version 7 of FreezerPro® software 2Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2
... April 5, 2011 Embryo Donation International ... facilities in the United States, officially opened today to ... globe desiring to build a family.     ... mission is to reduce the number of frozen ...
... YORK, April 5, 2011 Reportlinker.com announces that ... its catalogue: DNA Sequencing - ... http://www.reportlinker.com/p0203540/DNA-Sequencing---technologiesmarkets-and-companies.html This report briefly ... sequencing technologies, and their applications. Current large and ...
... PITTSBURGH, April 5, 2011 Mylan Inc. (Nasdaq: ... subsidiary Bioniche Pharma has launched Octreotide Acetate Injection ... Novartis, Sandostatin®, a treatment for a rare hormonal ... used to suppress or inhibit severe diarrhea associated ...
Cached Biology Technology:A New Company Is Born - Embryo Donation International 2Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies 2Mylan Launches Generic Version of Sandostatin® 2
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... today called for Europe to invest more funds into the ... crucial role in the function of human cells and which ... diabetes to Alzheimer,s. Common lipids such as cholesterol are ... of cells and tissues, but human cells contain thousands of ...
... got a shot of youthful vigor in a stem cell ... the path for research on new treatments for age-related degenerative ... In a new study to be published June 15 ... , researchers identified two key regulatory pathways that control how ...
... on June 13, 2008, Singapore scientists at the ... of Singapore (NUS) unveil an atlas that showing the ... factors) that are critical for maintaining the embryonic stem ... sequencing technology, the scientists discovered over 3,000 hotspots. These ...
Cached Biology News:Europe-wide investment in lipid research will help tackle disease, says new report 2Stem cell researchers give old muscle new pep 2Stem cell researchers give old muscle new pep 3Stem cell researchers give old muscle new pep 4Wealth of genomic hotspots discovered in embryonic stem cells 2
... Alkaline Phosphatase Conjugation ... Fluorescein Isothiocyanate Conjugation R. Phycoerythrin Conjugation ... Alexa Fluor 488 Conjugation Alexa Fluor ... Rpe-Alexa Fluor 750 Conjugation Apc-Alexa ...
Qa-1 (6A8.6F10)...
Human Cell Line Slides...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
Biology Products: